Gerard Marek
About Gerard Marek
Gerard Marek is the CMO with over 25 years of experience in early clinical development and discovery, having held notable positions at Yale University, Pfizer, Eli Lilly and Company, and Astellas Pharma.
Gerard Marek CMO
Gerard Marek is the Chief Medical Officer (CMO) with a notable track record in the pharmaceutical and medical fields. He brings over 25 years of experience in early clinical development and discovery, making significant contributions to the industry. His roles have spanned various major pharmaceutical companies and academic institutions, highlighting his comprehensive expertise and leadership in medical and psychiatric research.
Gerard Marek Yale University
Gerard Marek served as an Assistant Professor of Psychiatry at Yale University School of Medicine, contributing to academic and clinical research. In this role, he was involved in both the educational and research missions of the institution, focusing on psychiatric studies and furthering the field of psychiatry through academic endeavors.
Gerard Marek at Pfizer
Gerard Marek held the position of Associate Director at Pfizer, one of the world's leading pharmaceutical companies. During his tenure, he was responsible for overseeing significant projects and initiatives related to psychiatric disorders, playing a crucial role in the development and discovery efforts within the company.
Gerard Marek at Eli Lilly and Company
At Eli Lilly and Company, Gerard Marek served as the Psychiatric Disorders Discovery Biology CSO. In this position, he led the psychiatric disorders discovery team, guiding research and development projects to advance the understanding and treatment of psychiatric conditions. His work contributed to the company's innovations and strategic advancements in psychiatric medicine.
Gerard Marek at Astellas Pharma
Gerard Marek also served as Global Medical Lead at Astellas Pharma, where he directed global medical strategies and initiatives. In this role, he was responsible for aligning medical approaches with the company's global objectives, ensuring that medical research and development met international standards and addressed global health needs effectively.